Recursion Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

기사 요약

Recursion Pharmaceuticals (NASDAQ:RXRX) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by